Pharma Focus Europe
ThermoFisher Scientific - Custom and Bulks

The Ground breaking Commencement of Lek's $400M Biopharmaceutical Production Center Project in Lendava

Introduction:

Initiation of construction for Lek's advanced biopharmaceutical production center in Lendava is underway

Features:

The construction will occur on Lek's existing site in Lendava and involves three planned facilities.

The facility's primary objectives include generating energy products for current production demands and facilitating future drug substance production, particularly for biosimilars.

The combined surface area of the three facilities will be 40,000 m2.

The project will create 330 new jobs, contributing to the advancement of the pharmaceutical industry in the Pomurje region.

Biosimilars play a crucial role in saving costs and enhancing the sustainability of healthcare systems.

Biopharmaceutical production demands high purity standards with minimal environmental impact.

The center incorporates the best available technology to reduce energy consumption and resource use.

The expansion of Lek's biosimilar portfolio is a response to the growing demand for accessible treatments in Europe.

The center is designed to include state-of-the-art production and storage facilities and is expected to be operational by the end of 2026.

Specifications:

Name    Lek's

Type      Construction

Year        2026

magazine-slider-img
Get instant
access to our latest e-book
Pall+CytivaAdvertisement
patheon - Mastering API production at every scaleLab Indonesia 20247th Pharma Packaging and Labelling Forum 2024Future Labs Live - 2024World Orphan Drug Congress 2024World Vaccine Congress Europe 2024Sartorius Webinar - Pave Your Weigh to Accurate Analytical ResultsEUROPEAN PHARMA OUTSOURCING SUMMIT 2024patheon - Revolutionizing PharmaWorld Vaccine Congress Europe 2024